Venture-backed Dialogue buys medtech platform DXA
Dialogue Technologies has acquired DXA, a Montréal-based artificial intelligence-enabled medical technology platform. Terms weren't disclosed. Founded in 2015, DXA developed a tool for automating triage, medical charting and diagnosis. It can be used in most provider-patient interactions, from primary care to chronic and specialized care. Dialogue said the technology complements its virtual care and telemedicine offering and will allow it to explore new partnerships with healthcare providers and insurers. Earlier this year, Montréal-based Dialogue closed a $12 million Series A financing led by White Star Capital.
9 November 2018•3 mins read
